Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

The collagen receptor uPARAP/Endo180 in tissue degradation and cancer (Review)

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Annexin A2 and cancer: A systematic review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Prevalence of chromosomal rearrangements involving non-ETS genes in prostate cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Carboplatin treatment of antiestrogen-resistant breast cancer cells

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Arginase 1-based immune modulatory vaccines induce anti-cancer immunity and synergize with anti-PD-1 checkpoint blockade

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The Urokinase Receptor (uPAR) as a "Trojan Horse" in Targeted Cancer Therapy: Challenges and Opportunities

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. The collagen receptor uparap in malignant mesothelioma: A potential diagnostic marker and therapeutic target

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Osteosarcoma and Metastasis Associated Bone Degradation-A Tale of Osteoclast and Malignant Cell Cooperativity

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  5. Loss of Ambra1 promotes melanoma growth and invasion

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

The collagen receptor uPARAP/Endo180, the product of the MRC2 gene, is a central component in the collagen turnover process governed by various mesenchymal cells. Through the endocytosis of collagen or large collagen fragments, this recycling receptor serves to direct basement membrane collagen as well as interstitial collagen to lysosomal degradation. This capacity, shared only with the mannose receptor from the same protein family, endows uPARAP/Endo180 with a critical role in development and homeostasis, as well as in pathological disruptions of the extracellular matrix structure. Important pathological functions of uPARAP/Endo180 have been identified in various cancers and in several fibrotic conditions. With a particular focus on matrix turnover in cancer, this review presents the necessary background for understanding the function of uPARAP/Endo180 at the molecular and cellular level, followed by an in-depth survey of the available knowledge of the expression and role of this receptor in various types of cancer and other degenerative diseases.

OriginalsprogEngelsk
TidsskriftInternational Journal of Oncology
Vol/bind47
Udgave nummer4
Sider (fra-til)1177-88
ISSN1019-6439
DOI
StatusUdgivet - 12 aug. 2015

ID: 45654461